Heartworm Treatment Data Reinforces the Case for Prevention as Shelter Study Highlights Cost Barriers to Full Protocols

New research showing that a shortened two-dose melarsomine regimen cleared heartworm infection in 96% of shelter dogs underlines an uncomfortable reality for veterinary practice — that treatment protocols are being adapted around cost and access constraints, making consistent year-round prevention the far more reliable and affordable route to protecting dogs.

A study published in Parasites & Vectors reviewing 1,246 shelter dogs treated at Miami-Dade Animal Services between 2014 and 2024 found that a two-dose melarsomine regimen, combined with doxycycline and a macrocyclic lactone, cleared infection in 96% of cases tested — broadly comparable to the standard three-dose protocol for class 1 and class 2 disease.

The finding is clinically useful, but the wider message is preventive. Conventional heartworm treatment remains expensive, prolonged and demanding — often involving weeks of strict exercise restriction, repeat injections and significant owner compliance. Guidelines continue to identify the three-dose protocol as the preferred option across disease stages, noting the two-dose alternative primarily for rescue and shelter settings where finances or timing are constrained. That framing is telling: the shortened protocol exists largely because full treatment is unaffordable for many.

Prevention avoids the problem entirely. Year-round macrocyclic lactone administration remains highly effective, dramatically cheaper than treatment, and carries none of the clinical risk associated with killing adult worms in the pulmonary arteries. The economics are stark — a year of prevention typically costs a fraction of a single treatment course.

The 2026 research picture supports a broader shift toward flexible, prevention-led control. A March meta-analysis found non-arsenical protocols using moxidectin and doxycycline effective, while an April study in Parasites & Vectors highlighted a new combination chewable as a practical prevention option, expanding the tools available to keep dogs from ever requiring treatment.

Reference: Jacobson, L.S., DiGangi, B.A., Serrano, M.A. et al. A retrospective comparison of two-dose and three-dose melarsomine, with doxycycline and a macrocyclic lactone, in 1246 shelter dogs.
Parasites Vectors 19, 359 (2026).
https://doi.org/10.1186/s13071-026-07344-x